JenniferNicoleBrudnoMD

Hematology • Baltimore, MD

Physician

Join to view full profile

Are you Dr. Brudno?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 10 invites waiting!
Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

Office
600 N Wolfe St
Park 307
Baltimore, MD 21287
Phone+1 404-803-3741

Summary

Dr. Jennifer Brudno, MD is a hematologist in Baltimore, Maryland. She is currently licensed to practice medicine in Maryland and District of Columbia.

Education & Training

Emory University School of MedicineClass of 2010
Johns Hopkins UniversityResidency, Internal Medicine
National Institutes of Health Clinical CenterFellowship, Medical Oncology
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology

Certifications & Licensure

DC State Medical License 2013 - 2024
MD State Medical License 2013 - 2014
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

433 citations
Allogeneic T Cells That Express an Anti-CD19 Chimeric Antigen Receptor Induce Remissions of B-Cell Malignancies That Progress After Allogeneic Hematopoietic Stem-Cell ...
Jennifer N. Brudno, Robert Somerville, Victoria Shi, Jeremy J. Rose, David Halverson
Journal of Clinical Oncology. 2016-09-19
1720 citations
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
Daniel W. Lee, Bianca Santomasso, Frederick L. Locke, Armin Ghobadi, Cameron J. Turtle
Biology of Blood and Marrow Transplantation. 2019-04-01
907 citations
Toxicities of chimeric antigen receptor T cells: recognition and management.
Jennifer N. Brudno, James N. Kochenderfer
Blood. 2016-06-30

Press Mentions

BCMA-Targeting CAR T-cell Therapy Shows High Response Rate in Pretreated MyelomaDecember 1st, 2018
CAR-T Tx Shifts into First Gear in Lung CancerOctober 7th, 2018
Does CAR T-cell Therapy Induce Remission Following AlloHCT in Patients with B-cell Malignancies?April 28th, 2016